Clinical trial
Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women
NCT00440375 · Baskent University, Other · Completed
Key facts
| NCT number | NCT00440375 |
|---|---|
| Title | Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women |
| Lead sponsor | Baskent University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus, Obesity, Menopause |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 82 |
| Start date | Jun 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Feb 27, 2007 |
| Last update posted | Feb 27, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: